Scilex (SCLX) Competitors $0.33 -0.01 (-1.70%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$0.34 +0.01 (+2.18%) As of 02/21/2025 07:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends SCLX vs. CYRX, CRVS, PRME, ATYR, MNPR, TRVI, ALLO, CMPS, KRRO, and OLMAShould you be buying Scilex stock or one of its competitors? The main competitors of Scilex include Cryoport (CYRX), Corvus Pharmaceuticals (CRVS), Prime Medicine (PRME), Atyr PHARMA (ATYR), Monopar Therapeutics (MNPR), Trevi Therapeutics (TRVI), Allogene Therapeutics (ALLO), COMPASS Pathways (CMPS), Korro Bio (KRRO), and Olema Pharmaceuticals (OLMA). These companies are all part of the "pharmaceutical products" industry. Scilex vs. Cryoport Corvus Pharmaceuticals Prime Medicine Atyr PHARMA Monopar Therapeutics Trevi Therapeutics Allogene Therapeutics COMPASS Pathways Korro Bio Olema Pharmaceuticals Scilex (NASDAQ:SCLX) and Cryoport (NASDAQ:CYRX) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, profitability, community ranking, earnings, analyst recommendations, media sentiment, institutional ownership, dividends and valuation. Do institutionals and insiders hold more shares of SCLX or CYRX? 69.7% of Scilex shares are held by institutional investors. Comparatively, 92.9% of Cryoport shares are held by institutional investors. 8.7% of Scilex shares are held by company insiders. Comparatively, 10.1% of Cryoport shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Is SCLX or CYRX more profitable? Cryoport has a net margin of -70.08% compared to Scilex's net margin of -159.10%. Scilex's return on equity of 0.00% beat Cryoport's return on equity.Company Net Margins Return on Equity Return on Assets Scilex-159.10% N/A -93.65% Cryoport -70.08%-13.35%-6.43% Which has more volatility & risk, SCLX or CYRX? Scilex has a beta of 1.06, suggesting that its share price is 6% more volatile than the S&P 500. Comparatively, Cryoport has a beta of 1.59, suggesting that its share price is 59% more volatile than the S&P 500. Does the MarketBeat Community prefer SCLX or CYRX? Cryoport received 232 more outperform votes than Scilex when rated by MarketBeat users. However, 100.00% of users gave Scilex an outperform vote while only 65.15% of users gave Cryoport an outperform vote. CompanyUnderperformOutperformScilexOutperform Votes11100.00% Underperform VotesNo VotesCryoportOutperform Votes24365.15% Underperform Votes13034.85% Do analysts rate SCLX or CYRX? Scilex currently has a consensus target price of $14.00, indicating a potential upside of 4,145.00%. Cryoport has a consensus target price of $12.29, indicating a potential upside of 97.52%. Given Scilex's stronger consensus rating and higher possible upside, research analysts plainly believe Scilex is more favorable than Cryoport.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Scilex 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00Cryoport 0 Sell rating(s) 3 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.57 Which has stronger valuation & earnings, SCLX or CYRX? Cryoport has higher revenue and earnings than Scilex. Cryoport is trading at a lower price-to-earnings ratio than Scilex, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioScilex$46.74M1.72-$114.33M-$0.83-0.40Cryoport$233.26M1.32-$99.59M-$3.38-1.84 Does the media favor SCLX or CYRX? In the previous week, Cryoport had 3 more articles in the media than Scilex. MarketBeat recorded 3 mentions for Cryoport and 0 mentions for Scilex. Cryoport's average media sentiment score of 0.45 beat Scilex's score of 0.00 indicating that Cryoport is being referred to more favorably in the news media. Company Overall Sentiment Scilex Neutral Cryoport Neutral SummaryCryoport beats Scilex on 10 of the 17 factors compared between the two stocks. Get Scilex News Delivered to You Automatically Sign up to receive the latest news and ratings for SCLX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SCLX vs. The Competition Export to ExcelMetricScilexBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$80.24M$3.13B$5.77B$8.98BDividend YieldN/A1.57%4.78%3.85%P/E Ratio-0.4030.1126.4618.82Price / Sales1.72386.73453.2580.30Price / CashN/A183.5344.0437.47Price / Book-0.303.567.634.64Net Income-$114.33M-$71.72M$3.18B$245.69M7 Day Performance-6.84%-2.46%-1.91%-2.66%1 Month Performance-25.05%-0.25%-0.19%-2.15%1 Year Performance-81.05%-12.31%16.70%12.90% Scilex Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SCLXScilex3.3655 of 5 stars$0.33-1.7%$14.00+4,145.0%-81.4%$80.24M$46.74M-0.4080CYRXCryoport2.5802 of 5 stars$6.82+0.1%$12.29+80.1%-61.4%$337.11M$233.26M-2.021,170Positive NewsCRVSCorvus Pharmaceuticals1.9049 of 5 stars$5.03-3.5%$12.38+146.0%+82.2%$323.23MN/A-5.4130News CoveragePRMEPrime Medicine2.5229 of 5 stars$2.42-2.0%$13.13+442.4%-65.1%$317.41MN/A-1.18234News CoverageATYRAtyr PHARMA2.8132 of 5 stars$3.78-3.2%$19.25+409.9%N/A$316.87M$350,000.00-4.0253Analyst ForecastAnalyst RevisionNews CoverageGap UpMNPRMonopar Therapeutics0.9189 of 5 stars$51.89+7.1%$43.00-17.1%+1,312.3%$316.53MN/A-26.3410TRVITrevi Therapeutics2.7475 of 5 stars$4.06-4.4%$9.31+129.7%+73.6%$311.71MN/A-9.2220News CoveragePositive NewsGap UpALLOAllogene Therapeutics2.8233 of 5 stars$1.49-1.7%$9.73+555.4%-51.1%$311.36M$90,000.00-0.95310Gap UpCMPSCOMPASS Pathways1.7049 of 5 stars$4.48+1.6%$33.60+650.0%-57.6%$306.52MN/A-2.04120KRROKorro Bio0.917 of 5 stars$32.23-6.9%$144.00+346.8%-51.4%$302.00MN/A0.0070News CoverageGap UpOLMAOlema Pharmaceuticals3.2661 of 5 stars$5.16-9.3%$28.75+457.2%-64.0%$295.67MN/A-2.3670 Related Companies and Tools Related Companies CYRX Alternatives CRVS Alternatives PRME Alternatives ATYR Alternatives MNPR Alternatives TRVI Alternatives ALLO Alternatives CMPS Alternatives KRRO Alternatives OLMA Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:SCLX) was last updated on 2/22/2025 by MarketBeat.com Staff From Our Partners[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Scilex Holding Please log in to your account or sign up in order to add this asset to your watchlist. Share Scilex With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SCLX Stock Alerts